TrialBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2012

Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantation.

Koen van Besien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.